Differential impacts of contact tracing and lockdowns on outbreak size in COVID-19 model applied to China

Cameron J. Browne; Hayriye Gulbudak; Joshua C. Macdonald

doi:10.1101/2020.06.10.20127860

Abstract

The COVID-19 pandemic has led to widespread attention given to the notions of “flattening the curve” during lockdowns, and successful contact tracing programs suppressing outbreaks. However a more nuanced picture of these interventions’ effects on epidemic trajectories is necessary. By mathematical modeling each as reactive quarantine measures, dependent on current infection rates, with different mechanisms of action, we analytically derive distinct nonlinear effects of these interventions on final and peak outbreak size. We simultaneously fit the model to provincial reported case and aggregated quarantined contact data from China. Lockdowns compressed the outbreak in China inversely proportional to population quarantine rates, revealing their critical dependence on timing. Contact tracing had significantly less impact on final outbreak size, but did lead to peak size reduction. Our analysis suggests that altering the cumulative cases in a rapidly spreading outbreak requires comprehensive targeted measures that decrease the reproduction number close to one, otherwise a swift lockdown may be needed.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

CJB, HG, and JCM are supported by a U.S. National Science Foundation RAPID grant (DMS-2028728). HG was also supported by NSF grant (DMS-1951759) and a grant from the Simons Foundation/SFARI($638193$). CJB is partially supported by an NSF grant (DMS-1815095).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

N/A

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes